Experience

Kenneth Guernsey

    • Intersect ENT Agrees to Sell to Medtronic for More Than $1 Billion 


    • Nuvation Bio to Combine With Panacea, a Special Purpose Acquisition Company 


    • Angion Biomedica – $92 Million IPO 


    • Portola Agrees to Sell to Alexion for $1.41 Billion 


    • Satsuma Pharmaceuticals – $83 Million IPO  


    • NGM Biopharmaceuticals - $107 Million IPO 


    • Criteo $230 Million Follow-On 


    • Medivation Agrees to Sell to Pfizer for $14 Billion 


    • Jawbone Acquisition of Body Media 


    • Atara – $63 Million IPO and Follow-On Offerings 


    • Cooley's Capital Markets Leadership Continues through 1H 2014 


    • Adamas Pharmaceuticals Initial Public Offering 


    • Versartis $145 Million IPO 


    • Criteo - $250 Million IPO 


    • Portola Pharmaceuticals $140 Million IPO 


    • Jawbone Acquisition of Body Media